Nasopharyngeal and serological anti SARS-CoV-2 IgG/IgA responses in COVID-19 patients

Journal of Clinical Virology Plus - Tập 1 - Trang 100041 - 2021
Bernadette Crescenzo-Chaigne1, Sylvie Behillil2, Vincent Enouf2, Nicolas Escriou3, Stephane Petres4, Marie Noelle Ungeheuer5, Jade Ghosn6, Sarah Tubiana7, Lila Bouadma8, Sylvie van der Werf1,2, Caroline Demeret1
1Molecular Genetics of RNA Viruses Unit, Institut Pasteur, UMR3569, CNRS, Université de Paris, 28 rue du Docteur Roux, 75015 Paris, France
2National Reference Center for Respiratory Viruses, Institut Pasteur, 28 rue du Docteur Roux, 75015 Paris, France
3Innovation lab: vaccines, Institut Pasteur, 28 rue du Docteur Roux, 75015 Paris, France
4Production and Purification of Recombinant Proteins Technological Platform, Center for technological resources and research, Institut Pasteur, 28 rue du Docteur Roux, 75015 Paris, France
5ICAReB platform, Institut Pasteur, 28 rue du Docteur Roux, 75015, Paris, France
6Infectious and Tropical Diseases Department, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Université de Paris, INSERM, IAME UMR 1137, Paris, France
7Center for Clinical Investigation, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Université de Paris, INSERM, IAME UMR 1137, Paris, Paris, France
8Medical and Infectious Diseases Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Bichat-Claude Bernard University Hospital, Université de Paris, INSERM, IAME UMR 1137, Paris, France

Tài liệu tham khảo

Hu, 2020, Characteristics of SARS-CoV-2 and COVID-19, Nat. Rev. Microbiol. Krammer, 2020, SARS-CoV-2 vaccines in development, Nature, 586, 516, 10.1038/s41586-020-2798-3 Maurya, 2020, Therapeutic development and drugs for the treatment of COVID-19, 109 Zhu, 2020, A Novel Coronavirus from patients with Pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017 Macpherson, 2008, The immune geography of IgA induction and function, Mucosal. Immunol., 1, 11, 10.1038/mi.2007.6 Chen, 2020, Rethinking mucosal antibody responses: IgM, IgG and IgD join IgA, Nat. Rev. Immunol., 20, 427, 10.1038/s41577-019-0261-1 Grzelak, 2020, A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations, Sci. Transl. Med., 12, eabc3103, 10.1126/scitranslmed.abc3103 Lescure, 2020, Clinical and virological data of the first cases of COVID-19 in Europe: a case series, Lancet Infect. Dis., 20, 697, 10.1016/S1473-3099(20)30200-0 Marklund, 2020, Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders, PLoS One, 15, 10.1371/journal.pone.0241104 Kowitdamrong, 2020, Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019, PLoS One, 15, 10.1371/journal.pone.0240502 Yazdanpanah, 2020, Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients, J. Med. Virol., jmv.26601 Cervia, 2021, Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19, J. Allergy Clin. Immunol., 147, 545, 10.1016/j.jaci.2020.10.040 Lou, 2020, Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset, Eur. Respir. J., 56, 10.1183/13993003.00763-2020 Isho, 2020, Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients, Sci. Immunol., 5, 10.1126/sciimmunol.abe5511 Chen, 2020, Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production, Cell, 10.1016/j.cell.2020.10.051 Wajnberg, 2020, Robust neutralizing antibodies to SARS-CoV-2 infection persist for months, Science, 370, 1227, 10.1126/science.abd7728 Gallais, 2020, Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without Seroconversion, Infect. Dis. (except HIV/AIDS)